Telmisartan Hydrochlorothiazide Plus Tablet 40/12.5 mg

Adult dose

For patients whose blood pressure is inadequately controlled with Telmisartan alone, take once daily with or without food, along with a beverage. The dosing can be selected from the combined preparation of Telmisartan/Hydrochlorothiazide 40/12.5 mg, 80/12.5 mg, or 80/25 mg, depending on blood pressure control status. Patients with mild to moderate renal impairment do not require dosage adjustment, but severe patients (creatinine clearance <30 mL/min) should not be administered this medication.

Child dose

The safety and efficacy of this medication have not been established in children under 18 years; therefore, it is not administered.

This medication should not be used in pregnant women as it can lead to serious problems for the fetus or newborn, especially during the 2nd and 3rd trimester. It should not be administered to patients with allergies to certain components, severely impaired liver or kidney function, or those with obstructive biliary diseases. Caution is required when using this medication in the elderly or in patients with elevated potassium levels, or liver dysfunction. Although this medication lowers blood pressure, side effects such as dizziness, hypotension, electrolyte imbalance, liver dysfunction, and skin rashes may occur. In particular, the diuretic component of this medication may alter electrolyte balance, increasing the risk of hypokalemia, hyperkalemia, and hyponatremia, so regular blood tests are necessary. This medication may interact with other antihypertensive drugs, lithium, potassium supplements, non-steroidal anti-inflammatory drugs, etc., so consultation with a doctor or pharmacist is essential. Women who are pregnant or planning to become pregnant should not use this medication, and breastfeeding women should also avoid it if possible. In case of overdose, it can lead to hypotension, arrhythmias, electrolyte imbalances, and dehydration, so contact a medical facility immediately. This medication is not recommended for use in children under 18 years as safety and efficacy have not been established. Drowsiness or dizziness may occur while taking this medication, so caution is advised when driving or operating dangerous machinery. This medication should be stored away from direct sunlight and out of reach of children, and it is important to take it immediately after removing it from the packaging.

Serious side effects

Hives, severe swelling (angioedema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, mucosal pain in mouth/eyes, shortness of breath or difficulty breathing, asthma attack, respiratory disturbances associated with cough + fever, yellowing of the skin or eyes (jaundice), profound lethargy, sudden and severe headache, lightning headache, seizures, confusion, visual disturbances, paralysis,

Mild side effects

• Bronchitis
• pharyngitis
• sinusitis
• hypokalemia
• hyperuricemia
• hyponatremia
• anxiety
• depression
• insomnia
• sleep disturbances

This medication should be stored in a tightly closed container to protect it from air and moisture. It is advisable to maintain storage temperature at room temperature between 1 degree and 30 degrees Celsius. This will help preserve the effectiveness and safety of the medication for a long time.

Appearance

White or off-white rectangular tablet

Package unit

30 tablets/box [10 tablets/Alu-Alu x 3], 30 tablets/bottle